The genital warts (condyloma acuminatum) market is predicted to grow from its current value of US$ 1.87 billion in 2023 to US$ 3 billion by 2033, with a CAGR of 4.84%. Due to the anticipated ...

Bahrain's crown prince announced on Wednesday plans to invest more than $17 billion in the United States at a meeting with President Donald Trumpfocused on trade, Iran and regional security issues.

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today reported the topline results from a Phase 2 ...

The patient was given fluid hydration in the emergency department. After numerous episodes of witnessed BRBPR, surgery was consulted. Meanwhile, a bleeding scan was done, which was normal. The patient ...

DUBLIN--(BUSINESS WIRE)--The "Genital Warts (Condylomata Acuminata) Ongoing Global Clinical Trials Analysis and Outlook" report has been added to ResearchAndMarkets.com's offering. Genital Warts ...

The number of reported cases of condyloma acuminatum has increased rapidly in recent years. While the viral etiology of these lesions has been established, differentiation from other papular growths ...

ATLANTA, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Aviragen Therapeutics, Inc. (NASDAQ:AVIR), a company focused on the discovery and development of direct-acting antivirals to treat infections that have ...

Nov 29 (Reuters) - Aviragen Therapeutics Inc: * AVIRAGEN THERAPEUTICS ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE 2 CLINICAL TRIAL OF TESLEXIVIR (BTA074) FOR THE TREATMENT OF CONDYLOMA * ...

A giant condyloma was identified in a young man with a history of HIV (CD4 count 300) who initially presented to the emergency department with painless rectal bleeding with clots for 36 hours. He ...